Navigation Links
Neuro Kinetics Appoints Dr. Terri Ives Clinical Director, Audiology
Date:12/3/2007

PITTSBURGH, Dec. 3 /PRNewswire/ -- Neuro Kinetics, Inc. (http://www.neuro-kinetics.com), manufacturers of noninvasive medical diagnostic equipment used worldwide for balance, vestibular and neurological disorder tests, said today that Dr. Terri Ives has been appointed clinical director, audiology.

Ives will manage the company's clinical testing, coordination of multi- site research projects, clinical support, regulatory compliance and educational/training outreach programs for audiologists and other specialists. She also will be involved in new product development and research and will help represent the company with professional associations.

Earlier this year, Neuro Kinetics introduced its I-Portal(R)-VNG (Video Nystagmography System) and I-Portal(R)-Super VNG, designed for in-office early-screening balance and dizziness testing by audiologists, as well as otolaryngologists, neurologists and others. The company also manufactures other medical devices, including the Neuro-Otologic Test Center (NOTC) featuring its renowned barany (rotational) chair.

"We are delighted that Dr. Ives has opted to continue her distinguished career with our company," Howison Schroeder, Neuro Kinetics president and CEO, said. "Terri brings a tremendous depth of knowledge and expertise about audiology and diagnosis of disorders related to it. She also has a rare combination of perspectives from her work as a clinician, researcher, instructor, and executive in both academia and the medical equipment field. Terri will play a significant role for our company as we continue to expand our presence in the audiology market."

Said Ives, "I am excited by the opportunity to work with the highly skilled team at Neuro Kinetics. This company is on the move forward with amazing technological advances and I'm thrilled to be part of it."

Before joining Neuro Kinetics, Ives held a number of managerial and re
'/>"/>

SOURCE Neuro Kinetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
2. New research shows how chronic stress worsens neurodegenerative disease course
3. NYU study points to lasting impact of mild hearing loss on neurological processes
4. Low level of neuronal receptor linked to mild cognitive impairment and Alzheimers disease
5. Special Conference: Women and Neurological Diseases
6. Neurobiological Technologies Reports Going Concern Qualification
7. Brandeis neuroscientist wins NIH directors Pioneer Award
8. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
9. Kids Vaccine Ingredient Not Likely Linked to Neurological Problems
10. Loss of gene leads to protein splicing and buildup of toxic proteins in neurons
11. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 2Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 3Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 4Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 5Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 6Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 7Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 8Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 9Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 10Health News:Winner Medical Reports Fourth Quarter and Fiscal 2009 Results 11Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5
Other Medicine News:Health News:Nation's First of its Kind Consumer Medication Return Initiative Creates Momentum for Safe Drug Disposal in the U.S. 2Health News:Nation's First of its Kind Consumer Medication Return Initiative Creates Momentum for Safe Drug Disposal in the U.S. 3Health News:Bread mold may hold secret to eliminating disease-causing genes 2Health News:Microbiologists receive top Canadian recognition 2Health News:Cane use may reduce risk of knee osteoarthritis progression 2Health News:Cane use may reduce risk of knee osteoarthritis progression 3Health News:Study affirms effectiveness of medication for juvenile rheumatoid arthritis 2Health News:Study affirms effectiveness of medication for juvenile rheumatoid arthritis 3Health News:Video/Online 'Games For Health' Come Of Age: Four Major Trends Now Emerging 2Health News:Video/Online 'Games For Health' Come Of Age: Four Major Trends Now Emerging 3Health News:Video/Online 'Games For Health' Come Of Age: Four Major Trends Now Emerging 4Health News:Video/Online 'Games For Health' Come Of Age: Four Major Trends Now Emerging 5
Other Medicine Technology:Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 2Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 3Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 4Amicus Therapeutics Announces Second Quarter 2008 Financial Results 2Amicus Therapeutics Announces Second Quarter 2008 Financial Results 3Amicus Therapeutics Announces Second Quarter 2008 Financial Results 4Amicus Therapeutics Announces Second Quarter 2008 Financial Results 5Amicus Therapeutics Announces Second Quarter 2008 Financial Results 6Amicus Therapeutics Announces Second Quarter 2008 Financial Results 7Amicus Therapeutics Announces Second Quarter 2008 Financial Results 8Amicus Therapeutics Announces Second Quarter 2008 Financial Results 9Amicus Therapeutics Announces Second Quarter 2008 Financial Results 10Amicus Therapeutics Announces Second Quarter 2008 Financial Results 11Amicus Therapeutics Announces Second Quarter 2008 Financial Results 12